What is it about?
The contrast-enhanced ultrasound (CEUS) using Sonazoid® could prove both hypervascularity in the early arterial phase and reticuloendothelial cell systems (Kupffer cell) in the mass in the delayed phase, which is the key to the diagnosis of an accessory spleen. The CEUS is a non-invasive imaging technique superior to endoscopic ultrasound fine-needle aspiration biopsy for diagnosing an accessory spleen.
Featured Image
Photo by Ray Hennessy on Unsplash
Why is it important?
CEUS using Sonazoid® is helpful in the diagnosis of an intrapancreatic accessory spleen mimicking a malignant tumor. So, it could help us avoid unnecessary surgeries.
Perspectives
Contrast-enhanced ultrasound can abolish unnecessary surgeries for the accessory spleen.
Ph.D., M.D. Taketoshi Fujimoto
Iida Hospital
Read the Original
This page is a summary of: Letter to the Editor: Usefulness of contrast-enhanced ultrasound--Intrapancreatic accessory spleen mimicking malignant tumor, Acta Radiologica Open, January 2020, SAGE Publications,
DOI: 10.1177/2058460119892412.
You can read the full text:
Contributors
The following have contributed to this page
